Actively Recruiting
Diagnosing Variable Primary Aldosteronism.
Led by Queen Mary University of London · Updated on 2025-06-08
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to see if there is a cyclical or exaggerated diurnal variation in aldosterone production in people with Primary Aldosteronism.
CONDITIONS
Official Title
Diagnosing Variable Primary Aldosteronism.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- People with clinically suspected Primary Aldosteronism (PA) who have not met diagnostic criteria, based on low renin (renin activity <0.5 nmol/h/L or renin mass <5 ng/L), plasma sodium >140 mmol/L, or plasma potassium <4 mmol/L
- Patients diagnosed with PA who had previous aldosterone samples less than 277 pmol/L, which usually would not qualify for confirmatory testing
- Patients with aldosterone test results done at different times showing variable production
- Willingness to consent and participate in the study
You will not qualify if you...
- Inability to stop beta-adrenoceptor antagonist therapy for 2 weeks
- Patients receiving end-of-life treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Queen Mary University of London
London, United Kingdom
Actively Recruiting
Research Team
Y
Yun Ni Lee
CONTACT
T
Tumi Kaminskas
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here